GLP-1 receptor agonists × glycemic control

TrialDiabetic medicine : a journal of the British Diabetic Association2011

Liraglutide improves treatment satisfaction in people with Type 2 diabetes compared with sitagliptin, each as an add on to metformin.

M Davies et al.PubMed ↗Publisher ↗

What the trial testedas reported · 658 people · 2011

No range given

Reported lower glycemic control, no range given

−0.88

As reported

difference −0.88, no interval

One number in the abstract

the abstract, start to end

with liraglutide 1.8 mg (difference = -0.88; P < 0.0001) and 1.2 mg (

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
−0.88
GLP-1 receptor agonistsGlycemic control
1 / 3

24 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 21309842